Mackenzie Financial Corp Abiomed Inc Transaction History

Mackenzie Financial Corp

$66.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 07, 2022	SELL	$242.49 - $301.46 $1.82 Million - $2.26 Million	-7,513 Reduced 39.91%	11,313 $2.78 Million
Q2 2022 Aug 10, 2022	SELL	$224.73 - $338.64 $16,405 - $24,720	-73 Reduced 0.39%	18,826 $4.66 Million
Q1 2022 May 13, 2022	SELL	$277.25 - $366.29 $1.24 Million - $1.63 Million	-4,461 Reduced 19.1%	18,899 $6.26 Million
Q4 2021 Feb 14, 2022	SELL	$300.63 - $371.35 $252,529 - $311,934	-840 Reduced 3.47%	23,360 $8.39 Million
Q3 2021 Nov 08, 2021	BUY	$310.19 - $376.2 $2.76 Million - $3.34 Million	8,886 Added 58.03%	24,200 $7.88 Million
Q2 2021 Aug 11, 2021	BUY	$262.71 - $351.17 $244,320 - $326,588	930 Added 6.47%	15,314 $4.78 Million
Q1 2021 May 14, 2021	BUY	$285.92 - $355.13 $158,113 - $196,386	553 Added 4.0%	14,384 $4.59 Million
Q4 2020 Feb 10, 2021	BUY	$251.88 - $324.2 $863,444 - $1.11 Million	3,428 Added 32.95%	13,831 $4.48 Million
Q3 2020 Nov 13, 2020	SELL	$255.22 - $317.0 $533,920 - $663,164	-2,092 Reduced 16.74%	10,403 $2.88 Million
Q2 2020 Aug 13, 2020	BUY	$141.4 - $257.09 $831,997 - $1.51 Million	5,884 Added 89.0%	12,495 $3.02 Million
Q1 2020 May 14, 2020	BUY	$130.51 - $196.01 $682,958 - $1.03 Million	5,233 Added 379.75%	6,611 $959,000
Q4 2019 Feb 13, 2020	BUY	$159.31 - $223.54 $219,529 - $308,038	1,378 New	1,378 $235,000
Q1 2019 May 15, 2019	SELL	$276.39 - $362.25 $8.85 Million - $11.6 Million	-32,037 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$281.08 - $444.25 $34,010 - $53,754	121 Added 0.38%	32,037 $10.4 Million
Q3 2018 Nov 15, 2018	SELL	$354.53 - $449.75 $539,240 - $684,069	-1,521 Reduced 4.55%	31,916 $14.4 Million
Q2 2018 Aug 13, 2018	BUY	$278.07 - $446.21 $9.3 Million - $14.9 Million	33,437 New	33,437 $13.7 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account